Michiaki Fukui

12.1k total citations
447 papers, 8.8k citations indexed

About

Michiaki Fukui is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michiaki Fukui has authored 447 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Endocrinology, Diabetes and Metabolism, 138 papers in Physiology and 89 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michiaki Fukui's work include Diet and metabolism studies (66 papers), Nutrition and Health in Aging (64 papers) and Liver Disease Diagnosis and Treatment (64 papers). Michiaki Fukui is often cited by papers focused on Diet and metabolism studies (66 papers), Nutrition and Health in Aging (64 papers) and Liver Disease Diagnosis and Treatment (64 papers). Michiaki Fukui collaborates with scholars based in Japan, United States and United Kingdom. Michiaki Fukui's co-authors include Yoshitaka Hashimoto, Masahide Hamaguchi, Goji Hasegawa, Masahiro Yamazaki, Muhei Tanaka, Naoto Nakamura, Takuro Okamura, Mai Asano, Takao Kojima and Emi Ushigome and has published in prestigious journals such as JAMA, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Michiaki Fukui

430 papers receiving 8.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michiaki Fukui Japan 46 2.6k 2.6k 2.1k 1.6k 1.5k 447 8.8k
Niki Katsiki Greece 48 2.6k 1.0× 1.5k 0.6× 1.9k 0.9× 2.0k 1.3× 1.7k 1.1× 299 8.6k
Nan Hee Kim South Korea 55 2.8k 1.1× 3.0k 1.2× 2.7k 1.3× 1.1k 0.7× 2.0k 1.3× 337 10.7k
Sin Gon Kim South Korea 50 2.5k 0.9× 2.8k 1.1× 2.3k 1.1× 1.2k 0.8× 1.4k 0.9× 298 8.4k
Sei Hyun Baik South Korea 57 2.9k 1.1× 3.2k 1.2× 3.0k 1.5× 1.2k 0.7× 1.7k 1.1× 272 9.9k
Bong Soo South Korea 50 3.3k 1.3× 2.1k 0.8× 3.2k 1.5× 1.8k 1.1× 2.5k 1.7× 362 9.7k
Chul Woo Ahn South Korea 46 3.0k 1.2× 1.5k 0.6× 2.0k 1.0× 1.5k 1.0× 1.9k 1.3× 303 8.5k
Yuqian Bao China 51 3.6k 1.4× 2.0k 0.8× 2.2k 1.1× 1.8k 1.1× 3.9k 2.6× 424 10.7k
Eun Seok Kang South Korea 50 2.9k 1.1× 2.0k 0.8× 2.9k 1.4× 1.6k 1.1× 2.4k 1.6× 307 9.0k
Lee‐Ming Chuang Taiwan 55 3.7k 1.4× 2.9k 1.1× 2.9k 1.4× 2.5k 1.6× 3.2k 2.1× 335 11.9k
Wayne Huey‐Herng Sheu Taiwan 44 3.0k 1.2× 1.3k 0.5× 1.3k 0.6× 1.4k 0.9× 1.8k 1.2× 372 8.1k

Countries citing papers authored by Michiaki Fukui

Since Specialization
Citations

This map shows the geographic impact of Michiaki Fukui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiaki Fukui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiaki Fukui more than expected).

Fields of papers citing papers by Michiaki Fukui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiaki Fukui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiaki Fukui. The network helps show where Michiaki Fukui may publish in the future.

Co-authorship network of co-authors of Michiaki Fukui

This figure shows the co-authorship network connecting the top 25 collaborators of Michiaki Fukui. A scholar is included among the top collaborators of Michiaki Fukui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiaki Fukui. Michiaki Fukui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichikawa, Takahiro, Yoshitaka Hashimoto, Takuro Okamura, et al.. (2025). Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study. BMC Gastroenterology. 25(1). 202–202.
2.
Ushigome, Emi, Yoshitaka Hashimoto, Takafumi Osaka, et al.. (2025). Changes in food preferences after oral semaglutide administration in Japanese patients with type 2 diabetes: KAMOGAWA-DM cohort. Diabetes and Vascular Disease Research. 22(1). 1517160997–1517160997. 2 indexed citations
3.
Horinaka, Mano, et al.. (2025). Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRASG12D-Mutated Pancreatic Cancer. Molecular Cancer Therapeutics. 24(10). 1537–1545. 2 indexed citations
4.
Okamura, Takuro, et al.. (2024). Supplementation of Miso to a Western-Type Diet Stimulates ILC3s and Decreases Inflammation in the Small Intestine. Nutrients. 16(21). 3743–3743. 3 indexed citations
5.
Okamura, Takuro, Hiroshi Okada, Akihiro Obora, et al.. (2024). Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study. Journal of Diabetes Investigation. 15(12). 1788–1796. 2 indexed citations
6.
Okamura, Takuro, Hanako Nakajima, Saori Majima, et al.. (2023). Metabolic outcomes and changes in innate immunity induced by diesel exhaust particles airway exposure and high-fat high-sucrose diet. Life Sciences. 326. 121794–121794. 3 indexed citations
7.
Okada, Hiroshi, Masahide Hamaguchi, Yoshitaka Hashimoto, et al.. (2023). Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort. Diabetes Research and Clinical Practice. 202. 110794–110794. 6 indexed citations
8.
Nakajima, Hanako, Hiroshi Okada, Akinori Kogure, et al.. (2022). Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study. SHILAP Revista de lepidopterología. 3(4). 620–633. 2 indexed citations
9.
Hashimoto, Yoshitaka, Masahide Hamaguchi, Ayumi Kaji, et al.. (2022). Effects of Smoking on the Gut Microbiota in Individuals with Type 2 Diabetes Mellitus. Nutrients. 14(22). 4800–4800. 5 indexed citations
10.
Okamura, Takuro, Masahide Hamaguchi, Hiroyuki Tominaga, et al.. (2022). Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD RhapsodyTM VDJ CDR3 Assay. Cells. 11(10). 1623–1623. 7 indexed citations
11.
Takahashi, Fuyuko, Yoshitaka Hashimoto, Ayumi Kaji, et al.. (2021). Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study. Nutrients. 13(5). 1488–1488. 8 indexed citations
12.
Nakajima, Hanako, Yoshitaka Hashimoto, Saori Majima, et al.. (2021). Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes. Nutrients. 13(6). 2107–2107. 25 indexed citations
13.
Okada, Hiroshi, et al.. (2021). Association between variability in body mass index and development of type 2 diabetes: Panasonic cohort study. BMJ Open Diabetes Research & Care. 9(1). e002123–e002123. 9 indexed citations
14.
Tanaka, Muhei, et al.. (2020). Trunk muscle quality and quantity predict the development of metabolic syndrome and the increase in the number of its components in individuals without metabolic syndrome. Nutrition Metabolism and Cardiovascular Diseases. 30(7). 1161–1168. 8 indexed citations
15.
Okamura, Takuro, Yoshitaka Hashimoto, Ryosuke Sakai, et al.. (2018). Reduced Energy Intake Is Associated with Sarcopenia in Elderly Patients with Type 2 Diabetes–Kamogawa-DM Cohort Study. Diabetes. 67(Supplement_1). 5 indexed citations
16.
Imai, Saeko, Michiaki Fukui, Goji Hasegawa, et al.. (2011). Gender-Dependent Effect of AGT M235T Polymorphisms on Glycated Hemoglobin in Japanese Females with Type 2 Diabetes. Osaka Prefecture University Repository (Osaka Prefecture University). 9(9). 1–5.
17.
Fukui, Michiaki, Muhei Tanaka, Hitoshi Toda, et al.. (2011). Risk factors for development of diabetes mellitus, hypertension and dyslipidemia. Diabetes Research and Clinical Practice. 94(1). e15–e18. 25 indexed citations
18.
Uno, Kazuko, Mayumi Hirosaki, Kazuhiro Kakimi, et al.. (2007). Impaired IFN- α Production and the Risk of Cancer Development. Journal of Interferon & Cytokine Research. 27(12). 1013–1018. 7 indexed citations
19.
Ishii, Michiyo, Goji Hasegawa, Michiaki Fukui, et al.. (2005). Clinical and genetic characteristics of diabetic patients with high-titer (>10,000U/ml) of antibodies to glutamic acid decarboxylase. Immunology Letters. 99(2). 180–185. 6 indexed citations
20.
Fukui, Michiaki, et al.. (2001). Adult-Onset Type 1 Diabetes With DIDMOAD Syndrome–like Manifestations. Archives of Internal Medicine. 161(5). 767–767. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026